Qingfang Li

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 2

Top Topics

Glycemic Control

Anti Inflammatory Drugs

Pulmonary Fibrosis

Top Venues

Hepatology (Baltimore, Md.)

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yue Hu, Zheng Li, Zhiping Li, Yaqin Zhao, Qing Liu, Qingfang Li, Xinran Cheng
Letter to the Editor: Aspirin and GLP-1RAs-The missing confounders of empagliflozin for MASLD without diabetes mellitus? Hepatology (Baltimore, Md.) (2024)
Qingfang Li, Yuan Cheng, Zhe Zhang, Zhenfei Bi, Xuelei Ma, Yuquan Wei, Yanping Qian
Inhibition of ROCK ameliorates pulmonary fibrosis by suppressing M2 macrophage polarisation through phosphorylation of STAT3. Clinical and translational medicine 12 (10) (2022)